Kiora Debt Current vs Price to Book Value Analysis
KPRX Stock | USD 0.62 0.01 1.64% |
Trend analysis of Kiora Pharmaceuticals balance sheet accounts such as Total Current Liabilities of 3.2 M provides information on Kiora Pharmaceuticals' total assets, liabilities, and equity, which is the actual value of Kiora Pharmaceuticals to its prevalent stockholders. By breaking down trends over time using Kiora Pharmaceuticals balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Kiora |
About Kiora Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Kiora Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Kiora Pharmaceuticals Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Kiora Pharmaceuticals and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Kiora currently owns. An asset can also be divided into two categories, current and non-current.
Kiora Pharmaceuticals Balance Sheet Chart
Kiora Pharmaceuticals Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Kiora Pharmaceuticals uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, Kiora Pharmaceuticals' Common Stock is fairly stable compared to the past year. Current Deferred Revenue is likely to rise to about 4.9 M in 2024, whereas Total Assets are likely to drop slightly above 11.7 M in 2024. Add Fundamental
Total Assets
Total assets refers to the total amount of Kiora Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Kiora Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Kiora Pharmaceuticals balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Kiora Pharmaceuticals are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most indicators from Kiora Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Kiora Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kiora Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Kiora Stock please use our How to Invest in Kiora Pharmaceuticals guide.At this time, Kiora Pharmaceuticals' Selling General Administrative is fairly stable compared to the past year. Issuance Of Capital Stock is likely to rise to about 8.7 M in 2024, whereas Tax Provision is likely to drop (136.5 K) in 2024.
Kiora Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Kiora Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Kiora Pharmaceuticals fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 10.1M | 15.2M | 18.1M | 18.7M | 13.7M | 11.7M | |
Short Long Term Debt Total | 83.9K | 362.1K | 209.4K | 105.8K | 106.9K | 101.5K | |
Other Current Liab | 1.1M | 1.3M | 1.3M | 2.2M | 1.4M | 1.3M | |
Total Current Liabilities | 1.4M | 1.8M | 1.6M | 3.3M | 1.6M | 3.2M | |
Total Stockholder Equity | 6.6M | 7.0M | 9.2M | 11.4M | 6.1M | 6.4M | |
Property Plant And Equipment Net | 16.8K | 30.6K | 283.4K | 172.2K | 115.0K | 76.8K | |
Net Debt | (3.7M) | (823.6K) | (7.6M) | (5.9M) | (2.3M) | (2.5M) | |
Retained Earnings | (100.2M) | (108.3M) | (124.7M) | (134.5M) | (147.0M) | (154.3M) | |
Accounts Payable | 210.3K | 434.8K | 160.6K | 1.0M | 206.3K | 195.9K | |
Cash | 3.8M | 1.2M | 7.9M | 6.0M | 2.5M | 4.7M | |
Non Current Assets Total | 5.8M | 13.3M | 9.1M | 11.0M | 9.0M | 6.1M | |
Non Currrent Assets Other | 114.4K | 102.1K | 88.0K | 82.3K | 40.8K | 38.7K | |
Cash And Short Term Investments | 3.8M | 1.2M | 7.9M | 6.0M | 2.5M | 4.7M | |
Net Receivables | 4.9K | 91.0K | 529.6K | 1.4M | 2.0M | 2.2M | |
Common Stock Shares Outstanding | 79.5K | 114.8K | 241.1K | 732.3K | 4.8M | 5.1M | |
Liabilities And Stockholders Equity | 10.1M | 15.2M | 18.1M | 18.7M | 13.7M | 11.7M | |
Non Current Liabilities Total | 2.1M | 6.4M | 7.2M | 4.0M | 6.0M | 10.2M | |
Other Current Assets | 542.7K | 533.5K | 606.5K | 343.1K | 233.4K | 368.7K | |
Other Stockholder Equity | 106.7M | 115.3M | 133.9M | 146.0M | 153.2M | 93.1M | |
Total Liab | 3.5M | 8.2M | 8.8M | 7.3M | 7.6M | 12.5M | |
Total Current Assets | 4.3M | 1.8M | 9.0M | 7.7M | 4.7M | 5.6M | |
Accumulated Other Comprehensive Income | 139.5K | (802.0) | (86.4K) | (182.7K) | (182.8K) | (173.7K) | |
Short Term Debt | 83.9K | 48.3K | 118.8K | 105.8K | 47.1K | 44.7K | |
Common Stock | 40.8K | 55.6K | 126.6K | 18.0K | 77.1K | 101.9K | |
Intangible Assets | 4.1M | 9.7M | 8.7M | 10.7M | 8.8M | 7.9M | |
Other Liab | 1.5M | 2.1M | 6.1M | 7.1M | 8.2M | 8.6M | |
Net Tangible Assets | 7.2M | 4.9M | 3.3M | 9.1M | 10.4M | 10.9M | |
Capital Lease Obligations | 83.9K | 83.9K | 209.4K | 105.8K | 121.6K | 92.4K | |
Net Invested Capital | 6.6M | 7.3M | 9.2M | 11.4M | 13.1M | 7.6M | |
Non Current Liabilities Other | 1.7M | 5.3M | 6.5M | 3.3M | 3.8M | 3.5M | |
Net Working Capital | 2.9M | 37.8K | 7.4M | 4.4M | 5.1M | 5.3M | |
Property Plant Equipment | 43.5K | 16.8K | 30.6K | 283.4K | 325.9K | 342.2K | |
Capital Stock | 40.8K | 55.6K | 126.6K | 18.0K | 16.2K | 15.4K |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Kiora Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Kiora Pharmaceuticals' short interest history, or implied volatility extrapolated from Kiora Pharmaceuticals options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kiora Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Kiora Stock please use our How to Invest in Kiora Pharmaceuticals guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Complementary Tools for Kiora Stock analysis
When running Kiora Pharmaceuticals' price analysis, check to measure Kiora Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kiora Pharmaceuticals is operating at the current time. Most of Kiora Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kiora Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kiora Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kiora Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Kiora Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kiora Pharmaceuticals. If investors know Kiora will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kiora Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.78 | Revenue Per Share 0.002 | Return On Assets (0.38) | Return On Equity (1.37) |
The market value of Kiora Pharmaceuticals is measured differently than its book value, which is the value of Kiora that is recorded on the company's balance sheet. Investors also form their own opinion of Kiora Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Kiora Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kiora Pharmaceuticals' market value can be influenced by many factors that don't directly affect Kiora Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kiora Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Kiora Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kiora Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.